SCHEMBL1222425

SCHEMBL1222425

CCOC(=O)CNC(=O)CCc1ccc(O)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.55
CYP4F2 P78329 1/20 0.53
CYP4A11 Q02928 1/20 0.53
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
PPID Q08752 4/20 0.48
PPIB P23284 1/20 0.48
PPIA P62937 1/20 0.48
PPIG Q13427 1/20 0.48
CYP4Z1 Q86W10 1/20 0.46
POLB P06746 1/20 0.44
CNR2 P34972 1/20 0.44
KDM4E B2RXH2 1/20 0.44
F13A1 P00488 1/20 0.44
TRPV1 Q8NER1 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3665504 0.87 PPID (0.62) GAAHDAC2HDAC8PPIDPOLB
SCHEMBL28356401 0.86 POLB (0.63) POLBKMT2A
SCHEMBL1222683 0.85 HDAC4 (0.55) GAAPPIDPPIBPPIAPPIG
SCHEMBL304455 0.82 CYP4F2 (0.74) GAACYP4F2CYP4A11CYP4Z1KDM4E
SCHEMBL2034584 0.81 PPID (0.57) PPIDPPIBPPIAPPIGKDM4E
Ethane SCHEMBL27846059 0.81 CYP4F2 (0.72) GAACYP4F2CYP4A11CYP4Z1KDM4E
SCHEMBL3754312 0.80 CYP4F2 (0.57) GAACYP4F2CYP4A11HDAC2HDAC8
SCHEMBL14468017 0.79 HDAC2 (0.59) GAAHDAC2HDAC8POLBKDM4E
SCHEMBL435053 0.78 CYP4F2 (0.68) CYP4F2CYP4A11HDAC2HDAC8CYP4Z1
SCHEMBL3392569 0.78 GAA (0.62) GAAHDAC2HDAC8PPIDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199566-A1 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same BIONUTRIGEN CO., LTD. (KR) 2003-10-23 US claimed
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 US disclosed
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 US disclosed
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 US disclosed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 WO disclosed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 WO disclosed
US-7223793-B2 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same BIONUTRIGEN CO., LTD. (KR) 2007-05-29 US disclosed
US-20030199566-A1 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same BIONUTRIGEN CO., LTD. (KR) 2003-10-23 US disclosed
EP-0207684-B1 7-Oxabicycloheptane substituted diamide and its congener prostaglandin analogs SQUIBB & SONS INC (US) 1994-11-23 EP disclosed
US-4735962-A ANTICOAGULANTS, BRONCHODILATORS E. R. SQUIBB & SONS, INC. (US) 1988-04-05 US disclosed
US-4734424-A ANTICOAGULANTS E. R. SQUIBB & SONS, INC. (US) 1988-03-29 US disclosed
US-4734426-A CARDIOVASCULAR AGENTS E. R. SQUIBB & SONS, INC. (US) 1988-03-29 US disclosed
US-4663336-A ANTICOAGULANTS E. R. SQUIBB & SONS, INC. (US) 1987-05-05 US disclosed
EP-0207684-A2 7-Oxabicycloheptane substituted diamide and its congener prostaglandin analogs E.R. Squibb & Sons, Inc. (US) 1987-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 GAA 1264/4885CYP4F2 1364/4885CYP4A11 1299/4885
US-20030199566-A1 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same NCEH1, HMGCR, DBH GAA 3136/4885CYP4F2 270/4885CYP4A11 92/4885
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 GAA 1264/4885CYP4F2 1364/4885CYP4A11 1299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.